Psychopharmacology and Psychiatry Updates
Un podcast de Psychopharmacology Institute
Catégories:
213 Épisodes
-
Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction
Publié: 25/06/2024 -
Insomnia and Depression: A Tangled Web
Publié: 20/06/2024 -
ADHD Treatment During Pregnancy: Insights from Denmark
Publié: 15/06/2024 -
The Power of Nonpharmacologic Therapies in Fibromyalgia
Publié: 10/06/2024 -
Highlights From APA 2024: Key Insights on Psychopharmacology
Publié: 05/06/2024 -
Antidepressants in Pregnancy: Weighing the Evidence
Publié: 31/05/2024 -
Unraveling the Pharmacological Puzzle of Fibromyalgia
Publié: 26/05/2024 -
Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa
Publié: 21/05/2024 -
Beyond the Pain: Diagnosing Fibromyalgia
Publié: 17/05/2024 -
Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects
Publié: 11/05/2024 -
Mastering Clozapine: Adverse Effect Management
Publié: 06/05/2024 -
Preventing Depression and Anxiety Relapse in Youth
Publié: 01/05/2024 -
Charting the Clozapine Course: Titration and Monitoring
Publié: 26/04/2024 -
Smoking and Psychosis: Insights from the PATH Study
Publié: 21/04/2024 -
Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia
Publié: 16/04/2024 -
Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry
Publié: 11/04/2024 -
Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice
Publié: 06/04/2024 -
Zuranolone: A New Dawn for Postpartum Depression Treatment
Publié: 01/04/2024 -
Micronutrients for Psychiatric Disorders: Optimizing Clinical Use
Publié: 27/03/2024 -
Olanzapine in Pregnancy: Examining the Risks
Publié: 22/03/2024
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.